Templin; Michael V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Templin; Michael V..The latest application filed is for "delivery molecules for therapeutics".

Company Profile

0.6.19

Templin; Michael V. - Bothell WA
Templin; Michael V. - Carlsbad CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutics with conformationally restricted monomers Grant 10,023,863 - Templin , et al. July 17, 2	2018-07-17
Delivery Molecules For Therapeutics App 20170216227 - Fam; Renata ; et al.	2017-08-03
Una Oligomer Active Structures For Therapeutic Agents App 20160215293 - Templin; Michael V. ; et al.	2016-07-28
UNA oligomer structures for therapeutic agents Grant 9,340,789 - Templin , et al. May 17, 2	2016-05-17
Oligomers With Conformationally Restricted Monomers And Unlocked Nucleomonomers App 20150284717 - Templin; Michael V. ; et al.	2015-10-08
Processes And Compositions For Liposomal And Efficient Delivery Of Gene Silencing Therapeutics App 20150209283 - Polisky; Barry A. ; et al.	2015-07-30
Delivery Molecules For Therapeutics App 20150073038 - Fam; Renata ; et al.	2015-03-12
Nucleic Acid Compounds With Conformationally Restricted Monomers And Uses Thereof App 20130190383 - Vaish; Narendra K. ; et al.	2013-07-25
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics App 20130039970 - Polisky; Barry A. ; et al.	2013-02-14
Activity Generating Delivery Molecules App 20120277289 - Fam; Renata ; et al.	2012-11-01
UsiRNA Complexes App 20110313020 - Templin; Michael V. ; et al.	2011-12-22
Compositions And Methods For Topical Delivery Of Oligonucleotides App 20110213014 - Mehta; Rahul C. ; et al.	2011-09-01
Compositions and methods for topical delivery of oligonucleotides Grant 7,964,579 - Mehta , et al. June 21, 2	2011-06-21
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics App 20100112042 - Polisky; Barry A. ; et al.	2010-05-06
Compositions And Methods For Topical Delivery Of Oligonucleotides App 20090326045 - Mehta; Rahul C. ; et al.	2009-12-31
Tight Junction Modulating Peptide Components For Enhancing Mucosal Delivery Of Therapeutic Agents App 20090220435 - Quay; Steven C. ; et al.	2009-09-03
Uses Of Broad Spectrum Rnai Therapeutics Against Influenza App 20090042823 - Templin; Michael V. ; et al.	2009-02-12
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide App 20080318837 - Quay; Steven C. ; et al.	2008-12-25
Method Of Modulating Hematopoietic Stem Cells And Treating Hematologic Diseases Using Intranasal Parathyroid Hormone App 20080051332 - Templin; Michael V.	2008-02-28
Compositions and methods for topical delivery of oligonucleotides App 20050096287 - Mehta, Rahul C. ; et al.	2005-05-05
Compositions and methods for topical delivery of oligonucleotides Grant 6,841,539 - Mehta , et al. January 11, 2	2005-01-11
Liposomal oligonucleotide compositions for modulating RAS gene expression Grant 6,083,923 - Hardee , et al. July 4, 2	2000-07-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.